AGP Executive Report
Last update: 11 hours agoInnovative Medicine Access: EFPIA’s WAIT data says access to new therapies in Bulgaria fell to 46% (2021–2024) from 53% in the prior period, with industry warning pricing and reimbursement rules are keeping EU-approved treatments from reaching patients. Public Health Alert: Bulgaria recorded 317 measles cases from Jan 1 to May 24, 2026, versus just one in the same period of 2025, prompting reminders about mandatory vaccination schedules. Ebola Watch: WHO warns the DRC outbreak is spreading faster than containment, with over 1,000 cases and 220 deaths reported, while Europe monitors suspected cases. Environmental Health: Greenpeace Bulgaria staged a “TOXIC” banner action at Bobov Dol coal plant, urging limits on operations and a shift toward renewables, citing pollution risks to nearby communities. Care & Research: A Bulgarian-partner Egyptian vulture conservation project reached the LIFE Awards 2026 finalists, highlighting health-linked ecosystem protection. ALS in the Spotlight: French actor Pierre Deny (Emily in Paris) died at 69 after a sudden and severe ALS battle, renewing attention on the disease.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![Bulgaria risks falling further behind on innovative medicine access [Advocacy Lab]](https://www.euractiv.com/content/uploads/sites/2/2026/05/GettyImages-944237458.jpg)
![Bulgaria risks falling further behind on innovative medicine access [Advocacy Lab]](/images/news-fallback.svg)
